A5066820811- Kawasaki Disease and Coronary Complications
- Mechanical Circulatory Support Devices
- Respiratory viral infections research
- COVID-19 Clinical Research Studies
- Bacterial Infections and Vaccines
- Cardiac Structural Anomalies and Repair
- Infective Endocarditis Diagnosis and Management
- Cardiovascular Issues in Pregnancy
- Healthcare Systems and Challenges
- Influenza Virus Research Studies
- Diversity and Career in Medicine
- Trigeminal Neuralgia and Treatments
- Cardiovascular Effects of Exercise
- Cerebral Venous Sinus Thrombosis
- Inflammasome and immune disorders
- Coronary Artery Anomalies
- Acute Myocardial Infarction Research
- Migraine and Headache Studies
The University of Sydney
2020-2023
Sydney Children’s Hospitals Network
2020-2023
Children's Hospital at Westmead
2020-2021
The Paediatric Active Enhanced Disease Surveillance (PAEDS) network is an Australian hospital-based active surveillance system employing prospective case ascertainment for selected serious childhood conditions, particularly vaccine preventable diseases and potential adverse events following immunisation (AEFI). This report presents data 2019.Specialist nurses screened hospital admissions, emergency department records, laboratory other on a daily basis in seven paediatric tertiary referral...
Objective To present Australia-wide data on paediatric COVID-19 and multisystem inflammatory syndromes to inform health service provision vaccination prioritisation. Design Prospective, multicentre cohort study. Setting Eight tertiary hospitals across six Australian states territories in an established research surveillance network—Paediatric Active Enhanced Disease (PAEDS). Participants All children aged <19 years with SARS-CoV-2 infection including COVID-19, Paediatric Inflammatory...
The incidence of Kawasaki disease (KD) is reported to be increasing in some populations. We sought describe long-term trends the and epidemiology KD Australia over 25 years.Two nationally complete administrative datasets relevant were analysed compared. Australian Red Cross Lifeblood Supply Tracking Analysis Reporting System (STARS) recorded all doses immunoglobulin (IVIG) approved between January 2007 June 2016. Institute Health Welfare National Hospital Morbidity Database (NHMD) records...
Aim Australian and New Zealand guidelines recommend that live vaccines be postponed for 11 months after treatment of Kawasaki disease (KD) with intravenous immunoglobulin (IVIG). We aimed to describe patterns live‐vaccine administration KD treatment, focusing on the measles–mumps–rubella/measles–mumps–rubella–varicella (MMR/MMRV) vaccines, compare real‐world practice current recommendations. Methods combined data from inpatient Electronic Health Records Immunisation Register all children who...
Surgical mask, blue Protects me from the virus And her father's pain The author acknowledges patient and family.
Aim This study aimed to describe the current management practices for Kawasaki disease (KD) in Australia and New Zealand. Methods We performed a secondary analysis on Australian Zealand responses large international survey of clinicians' perspectives KD diagnosis management. Results There was general consensus among clinicians regarding indications intravenous immunoglobulin aspirin acute KD. less dose these agents, definition treatment‐resistant approach long‐term thromboprophylaxis....
We describe the case of a 5-month-old girl who presented to emergency department with left-sided periorbital edema and erythema. During assessment, she was observed suffer repeated hyper-acute episodes screaming associated hemifacial flushing, lacrimation rhinorrhea. This child diagnosed probable short-lasting unilateral neuralgiform headache attacks conjunctival injection tearing (SUNCT), one trigeminal autonomic cephalalgias. believe that this is youngest SUNCT for which there photographic...